
Christine Lu
@chrisluphd
Associate Professor of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute
ID: 2331264152
07-02-2014 04:07:11
245 Tweet
160 Followers
69 Following

This week's #HPI #ResearchWednesday is a cross-sectional study by #HPI's Christine Lu that examines the knowledge and attitudes of clinical pharmacists on Pharmacogenetic testing in China. Read the whole article here: mdpi.com/2075-4426/12/8…


New Article! "A Survey of Research Participants’ #Privacy- #Related #Experiences and Willingness to Share #Real- #World #Data with Researchers" Co authored by PROMoTeR_DPM Member, Christine Lu is published in JPM_MDPI buff.ly/3ASZg86


Developing useful, proven tools for rigorous assessment is something of a Department of Population Medicine specialty. Read on to learn how a team led by Christine Lu created a flexible, scalable tool to assess the impact of FDA regulatory actions on drug use: buff.ly/3FYNFbc International Society for Pharmacoepidemiology


Happy #ResearchWednesday! Check out an article by #HPI's #FangZhang and Christine Lu that assesses how privacy-related experiences may shape participants' willingness to share data with researchers. Read it here: mdpi.com/2075-4426/12/1…


New Article! " #Physicians’ #Knowledge, #Attitude, and #Experience of #Pharmacogenomic #Testing in China" Co authored by PROMoTeR_DPM Member, Christine Lu buff.ly/3judW7S


Very pleased to report that Omico Australia radical blueprint for better access to new biomarker dependent drugs through clinical trials is out in npj Journals Precision Oncology: rdcu.be/c2K0U Australian Rare Cancer (ARC) Portal Rare Cancers Australia Cancer Institute NSW NSW Medical Research SPHERE Cancer Clinical Academic Group

Using precision #oncology as an example, Department of Population Medicine's Christine Lu & colleagues propose an alternative, integrated model in which governments and industry share the risks and benefits of drug development. Online now in npj Journals #PrecisionOncology buff.ly/3jaD3wF


Thrilled to be at the launch of our research fellows Sydney Health Northern Sydney Local Health District Julia Pilowsky Christine Lu



In a nutshell: Omico Australia is developing a public:private partnership called #PrOSPeCT to attract greater investment in cancer trials in Australia.

🔜 Don’t miss out on tomorrow’s ‘Precision Medicine: Affording the Successes of Science’ #webinar with Professor DM Thomas & Vera Terry. If you’re passionate about advancing #PrecisionMedicine, this one’s for you. Register here: us02web.zoom.us/webinar/regist…


A new publication led by former @HealthPolicy_DPM fellow alison mcclean w/ Department of Population Medicine's #AnitaWagner & Christine Lu suggests that, while #biosimilar use is on the rise, the cost savings in #Medicare Part B remain unrealized. Read more in JCO Oncology Practice: buff.ly/3EJfamX


Potential cost savings in #Medicare Part B remain unrealized. Why, and possible solutions, in this new paper led by former Division of Health Policy and Insurance Research fellow alison mcclean w/Department of Population Medicine's #AnitaWagner, and Christine Lu:

“I look forward to working with an external mentor who is a senior researcher & leader in the sector & who would be able to provide strategic advice & holistic perspectives for career development & leadership.” Prof Christine Lu Christine Lu, University of Sydney Sydney Health Kolling Institute


Congratulations to our four University of Sydney #medicine and #health researchers who have been named Australian Academy of Health and Medical Sciences mentees for 2023! 🥼 Prof Christine Lu 🥼 Prof Philip Britton 🥼 A/Prof Melody Ding 🥼 A/Prof Sudarshini Ramanathan Find out more: aahms.org/news/celebrati…


Learn more about a University of Sydney Sydney Health Scholarship to join Northern Sydney Local Health District as a PhD student! The PhD will be supervised by Prof Christine Lu + is for domestic students. Apply by 13 Nov. Details here! → buff.ly/406qSlL

Great opportunity to expand your career working with Christine Lu Northern Sydney Local Health District #SydneyPharmacySchool

#HarvardMedicalSchool & #HPI researcher, Stephen Soumerai, alongside #UPenn, #USydney, #NortheasternU, and #LSE researchers found large reductions in pediatric mental health care following 2003 FDA Black Box Warnings. Read the article here: bit.ly/3Y1PbSm


Stephen Soumerai of Harvard Medical School et al, examined the adverse effects of FDA-issued black-box warnings on child and adolescent mental health outcomes such as reduced depression diagnosis and increased suicide rate. Read the full article here: bit.ly/4eZJGJr
